Illumina, Inc. (BVMF:I1LM34)
Brazil
· Delayed Price · Currency is BRL 140.71
+7.77 (5.84%)
At close: Dec 5, 2025
Illumina Revenue
Illumina had revenue of $1.08B USD in the quarter ending September 28, 2025, with 0.37% growth. This brings the company's revenue in the last twelve months to $4.29B, down -2.32% year-over-year. In the year 2024, Illumina had annual revenue of $4.37B, down -2.93%.
Revenue (ttm)
$4.29B
Revenue Growth
-2.32%
P/S Ratio
4.66
Revenue / Employee
$474.86K
Employees
9,030
Market Cap
106.66B BRL
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 29, 2024 | 4.37B | -132.00M | -2.93% |
| Dec 31, 2023 | 4.50B | -80.00M | -1.75% |
| Jan 1, 2023 | 4.58B | 58.00M | 1.28% |
| Jan 2, 2022 | 4.53B | 1.29B | 39.73% |
| Jan 3, 2021 | 3.24B | -304.00M | -8.58% |
| Dec 29, 2019 | Pro | Pro | Pro |
| Dec 30, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Jan 1, 2017 | Pro | Pro | Pro |
| Jan 3, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rede D'Or São Luiz | 54.20B |
| Raia Drogasil | 42.23B |
| Hypera | 6.97B |
| Fleury | 8.07B |
| Odontoprev | 2.53B |
| Diagnósticos da América | 12.57B |
| Empreendimentos Pague Menos | 14.27B |
| Blau Farmacêutica | 1.77B |